LLY-507   Click here for help

GtoPdb Ligand ID: 8239

PDB Ligand
Compound class: Synthetic organic
Comment: LLY-507 is a potent inhibitor of SMYD2 protein lysine methyltransferase activity, developed in a collaboration between the Structural Genomics Consortium (SGC) and Eli Lilly and Company [1].
Click here to link to the SGC's full list of epigenetics probes.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 11
Topological polar surface area 67.54
Molecular weight 574.34
XLogP 6.23
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES N#Cc1cc(cc(c1)c1ccccc1N1CCN(CC1)CCn1cc(c2c1cccc2)C)C(=O)NCCCN1CCCC1
Isomeric SMILES N#Cc1cc(cc(c1)c1ccccc1N1CCN(CC1)CCn1cc(c2c1cccc2)C)C(=O)NCCCN1CCCC1
InChI InChI=1S/C36H42N6O/c1-28-27-42(34-11-4-2-9-32(28)34)22-19-40-17-20-41(21-18-40)35-12-5-3-10-33(35)30-23-29(26-37)24-31(25-30)36(43)38-13-8-16-39-14-6-7-15-39/h2-5,9-12,23-25,27H,6-8,13-22H2,1H3,(H,38,43)
InChI Key PNYRDVBFYVDJJI-UHFFFAOYSA-N
Bioactivity Comments
LLY-507 is > 100-fold more selective for SMYD2 compared to other methyltransferases and other non-epigenetic targets [1].
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
SET and MYND domain containing 2 Primary target of this compound Hs Inhibitor Inhibition >7.8 pIC50 - 1
pIC50 >7.8 (IC50 <1.5x10-8 M) [1]